181 related articles for article (PubMed ID: 11454075)
1. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
Batterham MJ; Garsia R
Int J Androl; 2001 Aug; 24(4):232-40. PubMed ID: 11454075
[TBL] [Abstract][Full Text] [Related]
2. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials update in human immunodeficiency virus wasting.
Muurahainen N; Mulligan K
Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha B; Rajadhyaksha GC; Ray SK
J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
[TBL] [Abstract][Full Text] [Related]
5. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
6. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
7. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
Van Loan MD; Strawford A; Jacob M; Hellerstein M
AIDS; 1999 Feb; 13(2):241-8. PubMed ID: 10202830
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
Sattler FR; Jaque SV; Schroeder ET; Olson C; Dube MP; Martinez C; Briggs W; Horton R; Azen S
J Clin Endocrinol Metab; 1999 Apr; 84(4):1268-76. PubMed ID: 10199766
[TBL] [Abstract][Full Text] [Related]
11. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
[TBL] [Abstract][Full Text] [Related]
12. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
13. Megestrol acetate: promises and pitfalls.
Farrar DJ
AIDS Patient Care STDS; 1999 Mar; 13(3):149-52. PubMed ID: 10375262
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
15. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
[TBL] [Abstract][Full Text] [Related]
16. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Johansen KL; Mulligan K; Schambelan M
JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
18. The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative.
Timpone JG; Wright DJ; Li N; Egorin MJ; Enama ME; Mayers J; Galetto G
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):305-15. PubMed ID: 9071430
[TBL] [Abstract][Full Text] [Related]
19. Bodybuilders' body composition: effect of nandrolone decanoate.
van Marken Lichtenbelt WD; Hartgens F; Vollaard NB; Ebbing S; Kuipers H
Med Sci Sports Exerc; 2004 Mar; 36(3):484-9. PubMed ID: 15076791
[TBL] [Abstract][Full Text] [Related]
20. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
Hassager C; Riis BJ; Pødenphant J; Christiansen C
Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
